Drugs / [18F]MNI-444
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05009199 | Jun 2021 → May 2022 | — | Invicro | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]MNI-444 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05009199 ↗ |
| Modality | Diagnostic / imaging agent | “the positron emission tomography (PET) radiotracer, \[18F\]MNI-444” NCT05009199 ↗ |